Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 39, 2017 - Issue 7
289
Views
17
CrossRef citations to date
0
Altmetric
Original Research Paper

Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α

&
Pages 587-595 | Received 21 Sep 2016, Accepted 23 Mar 2017, Published online: 09 Apr 2017

References

  • Ojo O. Diabetes in ethnic minorities in UK: the role of diet in glucose dysregulationandprevalence of diabetes. J Food Nutr Disor. 2013;2:1–7.
  • Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070.10.1161/CIRCRESAHA.110.223545
  • Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(2):335–344.10.1113/jphysiol.2003.049478
  • Ding Y, Kantarci A, Hasturk H, et al. Activation of RAGE induces elevated O2− generation by mononuclear phagocytes in diabetes. J Leukocyte Biol. 2007;81(2):520–527.10.1189/jlb.0406262
  • Negre-Salvayre A, Salvayre R, Augé N, et al. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signaling. 2009;11(12):3071–3109.10.1089/ars.2009.2484
  • Sanz CM, Hanaire H, Vellas BJ, et al. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer’s disease. The Real.FR Cohort. Diabetic Med. 2012;29:541–548.10.1111/j.1464-5491.2011.03445.x
  • Acee, AM. Type 2 diabetes and vascular dementia: assessment and clinical strategies of care. Medsurg Nurs. 2012;21:349–384.
  • Carlsson CM. Type 2 diabetes mellitus, dyslipidaemia, and Alzheimer’s disease. J Alzheimers Dis. 2010;20:711–722.
  • Brito-Marques PR, Cabral-Filho JE. Influence of age and schooling on the performance in a modified mini-mental state examination version. Arq Neuropisiquiatr. 2005;63(3-A):583–587.
  • Carthery-Gourlart MT, Areza-Fegyveres R, Schultz RR, et al. Adaptação Transcultural da Escala de Avaliação de IncapacidadeemDemência [Disability assessment for dementia DaD]. ArqNeuropisiquiatr. 2007;63(3-B):916–919.
  • Danna SM, Graham E, Burns RJ, et al. Association between depressive symptoms and cognitive function in persons with diabetes mellitus: a systematic review. PLoS One. 2016;15:11–18.
  • Rodríguez-Sánchez E, Mora-Simón S, Patino-Alonso MC, et al. Cognitive impairment and dependence of patients with diabetes older than 65 years old in an urban area (DERIVA study). BMC Geriatr. 2016;16:16–33. DOI:10.1186/s12877-016-0208-3
  • Sherzai D, Sherzai A, Lui K, et al. The association between diabetes and dementia among elderly individuals: a nationwide inpatient sample analysis. J Geriatr Psychiatry Neurol. 2016;29(3):120–125.10.1177/0891988715627016
  • Lu ZK, Li M, Yuan J, et al. The role of cerebrovascular disease and the association between diabetes mellitus and dementia among aged medicare beneficiaries. Int J Geriatr Psychiatry. 2016;31(1):92–98.10.1002/gps.4293
  • Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry. 2006;60:1304–1305. PMID.10.1016/j.biopsych.2006.09.006
  • Hermida AP, McDonald WM, Steenland K, et al. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Expert Rev Neurother. 2012;12:1339–1350.10.1586/ern.12.127
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
  • Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Chem. 1979;95:351–358.
  • Koracevic D, Koracevic G, Djordjevic V, et al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54:356–361.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.10.1016/0022-3956(75)90026-6
  • Mitchell A. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43:411–431.10.1016/j.jpsychires.2008.04.014
  • Wood RY, Giuliano KK, Bignell CU, et al. Assessing cognitive ability in research: use of MMSE with minority populations and elderly adults with low education levels. J Gerontol Nurs. 2006;32:45–54.
  • O’Bryant SE, Humphreys JD, Smith GE. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65:963–967.
  • Fillenbaum G, Heyman A, Williams K, et al. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol. 1990;43:651–660.
  • Gagliardino JJ, Atanasov PK, Chan JC, et al. Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS). BMJ Open Diabetes Res Care. 2017;5(1):e000297.
  • Fatani SH, Babakr AT, NourEldin EM, et al. Lipid peroxidation is associated with poor control of type-2 diabetes mellitus. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S64–S67.
  • Zarei M, Farahnak Z, Hosseinzadeh-Attar MJ, et al. Lipid peroxidation and antioxidant enzymes activity in controlled and uncontrolled Type 2 diabetic patients. ARYA Atheroscler. 2016;12(3):118–123.
  • Savu O, Ionescu-Tirgoviste C, Atanasiu V, et al. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res. 2012;40:709–716.10.1177/147323001204000235
  • Rosales-Hernandez A, Cheung A, Podgorny P, et al. Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study. Lipids Health Dis. 2014;13:32. DOI:10.1186/1476-511X-13-32
  • Singh PP, Gupta S, Barjatiya MK, et al. Oxidantantioxidant dovetail hypothesis: let us not sprint before we stand. In: Singh PP, Gupta S, Barjatiya MK, editors. Free radicals and antioxidants in health and disease. Udaipur: Chaudhary Offset Print; 2007. p. 1–31.
  • Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687.10.1001/jama.295.14.1681
  • Hajipour S, Sarkaki A, Farbood Y, et al. Effect of Gallic acid on dementia type of alzheimere disease in rats: electrophysiological and histological studies. Basic Clin Neurosci. 2016;7(2):97–106.
  • Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes. 2002;51(4):1256–1262.10.2337/diabetes.51.4.1256
  • Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61(5):661–666.10.1001/archneur.61.5.661
  • Exalto LG, Whitmer RA, Kappele LJ, et al. An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp Gerontol. 2012;47:858–864.
  • Yaffe K, Barrett-Connor E, Lin F, et al. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59:378–384.10.1001/archneur.59.3.378
  • Lesser G, Kandiah K, Libow LS, et al. Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2001;12:138–145.
  • Hendrie HC, Hake A, Lane K, et al. Statin use, incident dementia and alzheimer disease in elderly African Americans. Ethn Dis. 2015;25(3):345–354.10.18865/ed.25.3.345
  • Kravitz E, Schmeidler J, Beeri MS. Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies. Endocrinol Metab Clin North Am. 2013;42:489–501.10.1016/j.ecl.2013.05.009
  • Gottschalk A, Ellger B. Whenever you lose connection, take intranasal insulin? Diabetes. 2015;64:687–688.10.2337/db14-1549
  • Ninomiya T. Diabetes mellitus and dementia. Curr Diab Rep. 2014;14:487.
  • Strachan MW. R D Lawrence Lecture 2010. The brain as a target organ in type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet Med. 2011;28:141–147.
  • Strachan MWJ, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7:108–114.10.1038/nrendo.2010.228
  • De Felice F, Gand Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 2014;63:2262–2272.10.2337/db13-1954
  • Rietzschel E, De Buyzere M. High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease? Biomarkers Med. 2012;6:19–34.10.2217/bmm.11.108
  • Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405.10.1016/S1474-4422(15)70016-5
  • Yang J, Fan C, Pan L, et al. C-reactive protein plays a marginal role in cognitive decline: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2015;30:156–165.10.1002/gps.v30.2
  • Ge X, Xu X-Y, Feng C-H, et al. Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments. BMC Neurol. 2013;13:110.10.1186/1471-2377-13-110
  • Chei C-L, Yamagishi K, Ikeda A, et al. C-reactive protein levels and risk of disabling dementia with and without stroke in Japanese: the Circulatory Risk in Communities Study (CIRCS). Atherosclerosis. 2014;236:438–443.10.1016/j.atherosclerosis.2014.07.036
  • Ding J, Strachan MW, Reynolds RM, et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes. 2010;59:2883–2889.10.2337/db10-0752
  • Hermida AP, McDonald WM, Steenland K, et al. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Expert Rev Neurother. 2012;12:1339–1350.10.1586/ern.12.127
  • Priyadarshini M, Kamal MA, Greig NH, et al. Alzheimer’s disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase. CNS Neurol Disord Drug Targets. 2012;11(4):482–489.10.2174/187152712800792767
  • Takeda S, Sato N, Uchio-Yamada K, et al. Diabetes accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA. 2010;107:7036–7041.10.1073/pnas.1000645107
  • Reale, MA, Di Nicola, M, Velluto, L, et al. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-b ex vivo activation of peripheral chemo-cytokines from Alzheimer’s disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr Alzheimer Res. 2013;11:608–622.
  • Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29–38.10.1001/archneurol.2011.233
  • Won SM, Lee JH, Park UJ, et al. Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp Mol Med. 2011;43(2):121–128.
  • Khan ZA, Chakrabarti S. Cellular signaling and potential new treatmen targets in diabetic retinopathy. Exp Diabetes Res. 2007; 2007. DOI:10.1155/2007/31867
  • Baker BJ, Park KW, Qin H, et al. IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia. Glia. 2010;58(9):1082–1093.10.1002/glia.v58:9
  • Pan W, Kastin AJ. Increase in TNF alpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol 2001, 170(2): 357–363.
  • Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29:1794–1799.10.2337/dc06-0506
  • van Harten B, Oosterman J, Muslimovic D, et al. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing. 2007;36:164–170.10.1093/ageing/afl180
  • Huang L, Yang L, Shen X, et al. Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes. Metab Brain Dis. 2016;31(2):347–353.10.1007/s11011-015-9756-z

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.